Mark D. Abel

849 total citations
10 papers, 530 citations indexed

About

Mark D. Abel is a scholar working on Organic Chemistry, Surgery and Molecular Biology. According to data from OpenAlex, Mark D. Abel has authored 10 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Mark D. Abel's work include Click Chemistry and Applications (2 papers), Signaling Pathways in Disease (2 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Mark D. Abel is often cited by papers focused on Click Chemistry and Applications (2 papers), Signaling Pathways in Disease (2 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Mark D. Abel collaborates with scholars based in United States and Canada. Mark D. Abel's co-authors include James B. Eisenkraft, Gregory W. Fischer, Meg A. Rosenblatt, Robert A. Levine, Lee Carrasco, Mohsen Daneshtalab, Ronald G. Micetich, Robert J. Suriani, Launa J. Aspeslet and Daniel J. Trepanier and has published in prestigious journals such as Anesthesiology, Nephrology Dialysis Transplantation and Therapeutic Drug Monitoring.

In The Last Decade

Mark D. Abel

10 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Abel United States	6	342	132	131	56	55	10	530
Alpaslan Apan Türkiye	10	166 0.5×	176 1.3×	10 0.1×	63 1.1×	15 0.3×	39	450
M. Giala Greece	11	162 0.5×	90 0.7×	39 0.3×	65 1.2×	3 0.1×	34	359
Jaime A. Wikinski Argentina	9	178 0.5×	77 0.6×	13 0.1×	67 1.2×	5 0.1×	22	406
Jens Rau Germany	7	288 0.8×	403 3.1×	11 0.1×	48 0.9×	12 0.2×	12	481
Lloyd Saberski United States	13	338 1.0×	65 0.5×	7 0.1×	44 0.8×	33 0.6×	29	542
Hee Jung Baik South Korea	14	334 1.0×	205 1.6×	16 0.1×	64 1.1×	2 0.0×	73	532
Dirk G. Snijdelaar Netherlands	11	136 0.4×	131 1.0×	40 0.3×	30 0.5×	2 0.0×	13	389
J. Gregus United States	6	197 0.6×	55 0.4×	6 0.0×	48 0.9×	5 0.1×	11	293
Danja Strümper Germany	12	268 0.8×	90 0.7×	11 0.1×	71 1.3×	4 0.1×	22	461
Nausherwan K. Burki United States	12	70 0.2×	20 0.2×	116 0.9×	110 2.0×	29 0.5×	20	619

Countries citing papers authored by Mark D. Abel

Since Specialization

Citations

This map shows the geographic impact of Mark D. Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Abel more than expected).

Fields of papers citing papers by Mark D. Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Abel. The network helps show where Mark D. Abel may publish in the future.

Co-authorship network of co-authors of Mark D. Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Abel. A scholar is included among the top collaborators of Mark D. Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Abel. Mark D. Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Huizinga, Robert B., Neil Solomons, & Mark D. Abel. (2016). SP671CALCINEURIN INHIBITION WITHOUT THERAPEUTIC DRUG MONITORING?. Nephrology Dialysis Transplantation. 31(suppl_1). i318–i319. 1 indexed citations

Rosenblatt, Meg A., Mark D. Abel, Gregory W. Fischer, & James B. Eisenkraft. (2007). Lipid Rescue from Bupivacaine Cardiac Arrest: A Result of Failure to Ventilate and Maintain Cardiac Perfusion?. Anesthesiology. 106(3). 637–638. 1 indexed citations

Abel, Mark D. & Lee Carrasco. (2006). Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 102(5). 582–590. 46 indexed citations

Rosenblatt, Meg A., et al.. (2006). Successful Use of a 20% Lipid Emulsion to Resuscitate a Patient after a Presumed Bupivacaine-related Cardiac Arrest. Anesthesiology. 105(1). 217–218. 393 indexed citations

Abel, Mark D. & Robert A. Levine. (2004). Muscle Contractions and Auditory Perception in Tinnitus Patients and Nonclinical Subjects. CRANIO®. 22(3). 181–191. 59 indexed citations

Maksymowych, Walter P., Gian S. Jhangri, Launa J. Aspeslet, et al.. (2002). Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.. PubMed. 29(8). 1646–52. 9 indexed citations

Trepanier, Daniel J., Mark D. Abel, Derrick G. Freitag, & Randall W. Yatscoff. (1999). Study of FK-binding Protein:FK506-metabolite Complexes by Electrospray Mass Spectrometry: Correlation to Immunosuppressive Activity. Therapeutic Drug Monitoring. 21(3). 274–274. 2 indexed citations

Abel, Mark D., et al.. (1998). The synthesis of aminimide‐containing azole antifungals. Journal of Heterocyclic Chemistry. 35(1). 193–199. 6 indexed citations

Suriani, Robert J. & Mark D. Abel. (1997). Acute superior vena cava syndrome resulting from inferior vena cava cross-clamping. Journal of Cardiothoracic and Vascular Anesthesia. 11(2). 197–200. 3 indexed citations

10.

Abel, Mark D., et al.. (1996). Synthesis of azolylalkylquinolines with cytotoxic activity. Journal of Heterocyclic Chemistry. 33(2). 415–420. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact